Evidence map›Paper›PMID 38602523›Full record

ArticlePathologie (Heidelberg, Germany)2024

[Rare differential diagnosis of an osteolytic lesion of the mandible in a young adult].

Hyunkyu Shin, Andreas Naros, Sinja Kieninger, Joachim Polligkeit, Falko Fend, Jakob Milla

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Pathologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hyunkyu ShinInstitut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland.
Andreas NarosKlinik und Poliklinik für Mund‑, Kiefer- und Gesichtschirurgie, Universitätsklinikum Tübingen, Tübingen, Deutschland.
Sinja KieningerInstitut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland.
Joachim PolligkeitKlinik und Poliklinik für Mund‑, Kiefer- und Gesichtschirurgie, Universitätsklinikum Tübingen, Tübingen, Deutschland.
Falko FendInstitut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland.
Jakob MillaInstitut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland. jakob.milla@med.uni-tuebingen.de.ORCID http://orcid.org/0009-0009-5319-5677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rarely occurring hematologic neoplasm in a young adult. Hematologic neoplasms were first described in 2008 and are now included in both accepted tumor classification systems, i.e., International Consensus Classification and World Health Organization. This hematologic neoplasm shows a characteristic ALK positivity in immunohistochemical examination and correspondingly, ALK fusion genes in the molecular analysis. Pathologists should be aware of this entity, particularly as it is challenging to differentiate from other more frequent neoplasms of the same disease group or mesenchymal neoplasm with ALK aberration.

Indexed as

OsteolysisAdultAnaplastic Lymphoma KinaseDiagnosis, DifferentialHumansMandibular NeoplasmsYoung AdultALK protein, humanAnaplastic Lymphoma KinaseALKALK-positive histiocytosisALK-rearranged histiocytosisALK-related histiocytosisHistiocytosis

Identifiers

PMID38602523
PMCPMC11199283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.